Cancer Mortality in Italy, 1993

Background Data and statistics are presented on cancer death certification for 1993 in Italy, updating previous publications covering the period 1955–1992. Methods Data for 1993 subdivided into 30 cancer sites are presented in 8 tables, including age-and sex-specific absolute and percentage frequencies of cancer deaths, and crude, age-specific and age-standardized rates, at all ages and truncated for the 35–64 year age group. Results Age-adjusted death certification rates (on the world standard population) for all neoplasms declined from 189.8 in 1992 (and a peak of 199.2 in 1986) to 187.8/100, 000 males in 1993, and remained stable around 100, 000 females. The favorable trends were even larger in middle and younger age males, but not in children below age 15, whose overall age-standardized cancer mortality rates increased for the fourth subsequent year. Lung cancer was the leading site of cancer mortality, with over 30, 900 deaths. For the fifth subsequent year, its rates in males declined, to reach 56.0/100,000. The decline in lung cancer rates is now established in Italian males and is substantial in middle age, whereas the rise in female lung cancer rates seems to have leveled off over the last few years. Rates for other major cancer sites (intestines, stomach, female breast, prostate, pancreas, leukemias and lymphomas) were stable, but some decrease was apparent also in 1993 for Hodgkin's disease. Conclusions Italian cancer mortality rates in 1993 were moderately favorable in males, due to the leveling of the tobacco-related epidemic, whereas no appreciable change was registered in females. The persisting unfavorable trends in childhood cancer mortality should be investigated.

Download Full-text

Cancer Mortality in Italy, 1992

Tumori Journal ◽

10.1177/030089169608200601 ◽

1996 ◽

Vol 82 (6) ◽

pp. 511-518 ◽

Cited By ~ 3

Author(s):

Adriano Decarli ◽

Carlo La Vecchia

Keyword(s):

Lung Cancer ◽

Cancer Mortality ◽

Mortality Rates ◽

Death Certification ◽

Female Breast ◽

Standard Population ◽

Younger Age ◽

Major Exception ◽

World Standard ◽

Male To Female

Background Data and statistics are presented on cancer death certification in Italy, updating previous publications covering the period 1955-1991. Methods Data for 1992 subdivided into 30 cancer sites are presented in 8 tables, including age- and sex-specific absolute and percentage frequencies of cancer deaths, and crude, age-specific and age-standardized rates, at all ages and truncated for the 35-64 year age group. Male to female ratios have also been tabulated, and trends in age-standardized rates for major cancer sites plotted from 1955 to 1992. Results Age-adjusted death certification rates (on the world standard population) for all neoplasms declined from 193.4 in 1991 to 189.8/100,000 males in 1992, and from 100.1 to 99.5/100,000 females. The favorable trends were even more marked in middle and younger age, but not in children below age 15, whose overall age-standardized cancer mortality rates were higher in 1992 than in 1989. Lung cancer was by far the leading site of cancer mortality, with over 30,700 deaths. For the fourth subsequent year, its rates in males declined, to reach 57.0/100,000, but continued to rise in females, to reach 8.0/100,000. Rates for other major cancer sites (intestines, stomach, female breast, prostate, pancreas) were stable or moderately favorable, but some increase was apparent also in 1992 for non-Hodgkin's lymphoma death rates. Conclusions Italian cancer mortality rates in 1992 were moderately favorable, with the major exception of the persistent spread of the tobacco-related lung cancer epidemic in females.

Download Full-text

Cancer Mortality in Italy, 1994, and an Overview of Trends from 1955 to 1994

Tumori Journal ◽

10.1177/030089169808400305 ◽

1998 ◽

Vol 84 (3) ◽

pp. 312-334 ◽

Cited By ~ 15

Author(s):

Adriano Decarli ◽

Carlo La Vecchia ◽

Cesare Cislaghi ◽

Eva Negri

Keyword(s):

Lung Cancer ◽

Cancer Mortality ◽

Cervix Uteri ◽

Death Certification ◽

Mortality Trends ◽

World Standard ◽

Males And Females ◽

Cancer Rates ◽

Hodgkin's Lymphomas ◽

Female Lung Cancer

Background Data and statistics are presented on cancer death certification in Italy, updating previous publications covering the period 1955-1993. Methods Data for 1994 and the quinquennium 1990-94 subdivided into 30 cancer sites are presented in 8 tables, including age- and sex-specific absolute and percentage frequencies of cancer deaths, and crude, age-specific and age-standardized rates, at all ages and truncated for the 35-64 year age group. Trends in age-standardized rates for major cancer sites are plotted from 1955 to 1994. Results The age-standardized (world standard) death certification rates from all neoplasms steadily declined from the peak of 199.2/100,000 males in 1988 to 186.3 in 1994, and in females from 102.5 in 1989 to 98.6 in 1994. Ever larger was the decline in truncated rates, for males from the peak of 275.1/100,000 in 1983 to 223.2 (-19%) in 1994, and for females from 151.6/100,000 in 1987 to 136.4 (-10%). A major component of the favourable cancer mortality trends in males was lung cancer (accounting for 31,000 deaths in both sexes combined in 1994), whose overall age-standardized rates declined from 60.3 in 1987-89 to 54.6/100,000 males in 1994 (-9%), and from the peak of 96.7 in 1983 at ages 35 to 64 to 72.7 in 1994 (-25%). In contrast, female lung cancer rates have remained stable from 1992 onwards, but have increased from 7.2 to 7.7 at all ages and from 10.6 to 11.0 at age 35-64 between 1985-89 and 1990-94. These different trends in the two sexes reflect the patterns and trends in smoking among Italian males and females. Conclusions Cancer mortality trends in Italy over the period 1990-94 were relatively favourable, mainly reflecting the decline in lung cancer rates in males, together with the persistent declines in gastric cancer in both sexes and in cervix uteri for women. Continuous advancements were registered for neoplasms amenable to treatment, essentially testicular cancer, Hodgkin's disease and childhood leukaemias. The major unfavourable trends were observed for non Hodgkin's lymphomas, and require therefore further monitoring, besides a clearer understanding of their determinants. Italy maintains an intermediate level of cancer mortality on a European scale, suggesting that further progress is possible, mostly for tobacco-related neoplasms in males.

Download Full-text

A Study of Tuberculosis and Cancer Mortality Rates with Special Reference to Lung Cancer Rates

British Journal of Cancer ◽

10.1038/bjc.1956.74 ◽

1956 ◽

Vol 10 (4) ◽

pp. 623-633 ◽

Cited By ~ 4

Author(s):

T G Paxon

Keyword(s):

Lung Cancer ◽

Special Reference ◽

Cancer Mortality ◽

Mortality Rates ◽

Cancer Rates

Download Full-text

Geographical Disparities of Lung Cancer Mortality Centered on Central Appalachia

International Journal of Applied Geospatial Research ◽

10.4018/ijagr.2014100103 ◽

2014 ◽

Vol 5 (4) ◽

pp. 35-53

Author(s):

Timothy S. Hare ◽

Chad Wells ◽

Nicole Johnson

Keyword(s):

Lung Cancer ◽

Cancer Mortality ◽

Spatial Clustering ◽

Lung Cancer Mortality ◽

Mortality Rates ◽

Factors Associated ◽

Level Data ◽

Central Appalachia ◽

Specific Factors ◽

Female Lung Cancer

This article explores regional disparities in lung cancer mortality for females and males and associated factors across central Appalachia and surrounding regions. It asks, how are lung cancer mortality rates distributed geographically, what are the relative contributions of specific factors to lung cancer disparities by sex, and how do the effects of these factors vary across the study area? This study is based on county-level data of potential determinants of disease to explore local effects on lung cancer mortality. It analyzes these data using a combination of spatial statistical analyses. The analysis shows that the spatial clustering of high lung cancer mortality rates differs for females and males. Additionally, the factors associated with lung cancer for females and males differ greatly. For instance, tobacco use is associated with male lung cancer mortality, but not with female lung cancer mortality. These factors also vary in their geographical relationships with female and male lung cancer mortality.

Download Full-text